These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30688217)

  • 1. Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease.
    González-Ramos J; Lamas C; Bellón T; Ruiz-Bravo E; RamIrez E; Lerma V; Lecumberri B
    Indian J Dermatol Venereol Leprol; 2020; 86(5):515-518. PubMed ID: 30688217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report.
    Zuo W; Wen LP; Li J; Mei D; Fu Q; Zhang B
    Medicine (Baltimore); 2019 May; 98(19):e15553. PubMed ID: 31083216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxic epidermal necrolysis after treatment with oseltamivir: case report].
    Luna P; Zuazaga M; Chede C; Entin E; Larralde M
    Arch Argent Pediatr; 2010 Jun; 108(3):e76-8. PubMed ID: 20544126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steven Johnson syndrome in a patient with Cushing's disease.
    Mustafa N; Periyasamy P; Kamaruddin N
    Med J Malaysia; 2009 Sep; 64(3):238-9. PubMed ID: 20527277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis associated with pembrolizumab.
    Cai ZR; Lecours J; Adam JP; Marcil I; Blais N; Dallaire M; Belisle A; Mathieu A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adefovir-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome.
    Chattopadhyay P; Sarma N
    Singapore Med J; 2011 Feb; 52(2):e31-4. PubMed ID: 21373727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
    Worswick S; Cotliar J
    Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir induced oral-only erythema multiforme.
    Siemieniak S; Yoo MJ
    Am J Emerg Med; 2022 May; 55():232.e1-232.e2. PubMed ID: 35168848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.
    Zhao Y; Liang W; Cai F; Wu Q; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608886. PubMed ID: 33391186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.